Marc Navre
17Patents
5h-index
23Co-inventors
62Inventor score
Filing activity: Mar 11, 2004 → Apr 1, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8815910B2 | Compounds and methods for inhibiting phosphate transport | Chemistry; Metallurgy | 7 | Active |
| US8809339B2 | Compounds and methods for inhibiting phosphate transport | Chemistry; Metallurgy | 7 | Active |
| US8815908B2 | Compounds and methods for inhibiting phosphate transport | Chemistry; Metallurgy | 7 | Active |
| US9408840B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder | Emerging Cross-Sectional Technologies | 6 | Active |
| US8916569B2 | Compounds and methods for inhibiting phosphate transport | Chemistry; Metallurgy | 5 | Active |
| US8541448B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | Emerging Cross-Sectional Technologies | 4 | Active |
| US10543207B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | Emerging Cross-Sectional Technologies | 3 | Active |
| US8969377B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | Emerging Cross-Sectional Technologies | 2 | Active |
| US11318129B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US9006281B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US9278102B2 | Compounds and methods for inhibiting phosphate transport | Chemistry; Metallurgy | 0 | Active |
| US9289430B2 | Compounds and methods for inhibiting phosphate transport | Chemistry; Metallurgy | 0 | Active |
| US9301951B2 | Compounds and methods for inhibiting phosphate transport | Chemistry; Metallurgy | 0 | Active |
| US9289429B2 | Compounds and methods for inhibiting phosphate transport | Chemistry; Metallurgy | 0 | Active |
| US12016856B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US7235672B1 | Probe, assay and kits for detecting 11β-hydroxysteroid dehydrogenase and modulators thereof | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7507552B1 | Crystallization of histone deacetylase 2 | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.